Select Medical Holdings CORP Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NYSE
Select Medical Holdings Corporation announced the completion of its acquisition by a consortium led by Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe (WCAS) for $16.50 per share.
NYSE
Select Medical Holdings Corporation has agreed to be acquired by Stallion Intermediate Corporation for $16.50 per share in cash, with key management and an equity investor rolling over significant equity.
NYSE
Select Medical Holdings Corp's Executive Chairman, Robert A. Ortenzio, has submitted a refined non-binding proposal to acquire all outstanding shares not already owned by the reporting persons for $16.00 per share in cash.
NYSE
Robert A. Ortenzio and Martin F. Jackson, along with the Estate of Rocco A. Ortenzio, propose to acquire all outstanding shares of Select Medical Holdings Corp not already owned by them for $16.00 to $16.20 per share in cash.